"Mouse models of cancer are used extensively to study tumor development and the effects of new therapies, but until now the tools to measure this effect have had depth limitations," said Dr. Rakesh Jain,  Director, Edwin L. Steele Laboratory for Tumor Biology at Harvard Medical School, and Enlight Biosciences Advisor.  "The ability to track abnormal vessel growth and normalization in vivo with high resolution throughout a tumor mass during therapeutic intervention is a powerful new capability that will be widely used in cancer research." 

The name Nexus 128 represents the convergence of light and sound in a powerful new imaging approach.  It employs a detector array consisting of 128 individual acoustic receiver elements arranged in a patented geometry.  The system generates multispectral, quantitative, three dimensional images of tumor vasculature and hemoglobin concentration in under 2 minutes, and completes volumetric anatomical scans in as little as 12 seconds.  "For the past several years, our research group has developed quantitative photoacoustic spectroscopy imaging techniques and applied them to mouse models of cancer," said Dr. Keith Stantz, faculty member of Purdue University.  "We have been using Endra's photoacoustic tomography prototype system regularly for the past year.  The simplified animal handling and high throughput allow us to image entire study groups within a couple of hours."

SOURCE Endra Life Sciences